RB1 controls differentiation through positive regulation of phosphoglycerate mutases

Most glycolytic enzymes are transcriptionally controlled by hypoxia-inducible factor-1α (HIF-1α) and/or MYC, however, phosphoglycerate mutases (PGAMs) are exceptional. Retinoblastoma tumor suppressor 1 (RB1) loss converts poorly spherogenic Trp53-null leiomyosarcoma cells to highly spherogenic. We determined a gene expression signature of RB1 loss-of-function in this setting and identified PGAM2 as a positive transcriptional target of RB1. Later, we found that RB1 positively controls PGAM1 as well in different tissues. RB1 deficiency induced a metabolic shift in the glycolytic pathway in a manner compatible with PGAM downregulation. Many of the metabolic features induced by RB1 loss were antagonized by PGAM overexpression. Furthermore, differentiation deficiency following RB1 loss was rescued by PGAM overexpression or pyruvate supplementation to varied degrees. These findings suggest that the RB1-PGAM1/2 axis at least partially controls RB1-dependent differentiation.

Authors

Institutions

Publication Details

Journal
Cell Death and Disease
Published
2025-07-24
DOI
https://doi.org/10.1038/s41419-025-07850-3
Citations
1
Primary Topic
Cancer, Hypoxia, and Metabolism
Type
article
Field-Weighted Citation Impact
0.94

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RB1 controls differentiation through positive regulation of phosphoglycerate mutases

Nobuyuki Okahashi, Teruo Kawada, Chiaki Takahashi, Hiroshi Shimizu et al.
1 citations
Cell Death and Disease
Cancer, Hypoxia, and Metabolism
0.94
article

RB1 controls differentiation through positive regulation of phosphoglycerate mutases

Nobuyuki Okahashi, Teruo Kawada, Chiaki Takahashi, Hiroshi Shimizu, Shunsuke Kitajima, Fumio Matsuda, Yujiro Takegami, Susumu Kohno, Paing Linn, Hou‐Yong Yu, Yuansong Wan, Naoko Nagatani
article en
1 citations

Abstract

Most glycolytic enzymes are transcriptionally controlled by hypoxia-inducible factor-1α (HIF-1α) and/or MYC, however, phosphoglycerate mutases (PGAMs) are exceptional. Retinoblastoma tumor suppressor 1 (RB1) loss converts poorly spherogenic Trp53-null leiomyosarcoma cells to highly spherogenic. We determined a gene expression signature of RB1 loss-of-function in this setting and identified PGAM2 as a positive transcriptional target of RB1. Later, we found that RB1 positively controls PGAM1 as well in different tissues. RB1 deficiency induced a metabolic shift in the glycolytic pathway in a manner compatible with PGAM downregulation. Many of the metabolic features induced by RB1 loss were antagonized by PGAM overexpression. Furthermore, differentiation deficiency following RB1 loss was rescued by PGAM overexpression or pyruvate supplementation to varied degrees. These findings suggest that the RB1-PGAM1/2 axis at least partially controls RB1-dependent differentiation.

Cell Death and DiseaseVol. 16(1)
Kanazawa University (JP), Tsurumi University (JP), Kanazawa Institute of Technology (JP), Cornell University (US), Kyoto University (JP), East Yangon General Hospital (MM), MIND Research Institute (US), Japanese Foundation For Cancer Research (JP), Weill Cornell Medicine (US), The University of Osaka (JP)
Naito Foundation, Kanazawa University, Ministry of Education, Culture, Sports, Science and Technology, Astellas Pharma, Ono Medical Research Foundation, Princess Takamatsu Cancer Research Fund, Japan Society for the Promotion of Science
Good health and well-being
Openalex Percentile: Top 22%
Cancer, Hypoxia, and Metabolism
0.94
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.